L

Launch One Acquisition Corp. (LPAA)

NGM – Real vaqt narxi. Valyuta: USD

10.77

-0.02 (-0.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

L

Launch One Acquisition Corp. (LPAA)

NGM – Real vaqt narxi. Valyuta: USD

10.77

-0.02 (-0.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

13.01.2026

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases

Videolar

No Data

There is no data to display

Press-relizlar

13.01.2026

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases

Search stocks

Launch One Acquisition Corp. (LPAA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Launch One Acquisition Corp. (LPAA)

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Videolar

No Data

Press-relizlar

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform